Canadian footballer Ismaël Koné's use of the "green whistle" for pain relief during a World Cup match has sparked interest. This handheld i...

A gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...

Americans face growing challenges affording healthcare. New data reveals a significant drop in those able to manage medical costs and acces...

Mayo Clinic researchers found a new way kidneys manage water. This discovery uses an old drug, probenecid, to reveal a pathway independent ...

Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...

A new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...

India's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...

The landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...

Artificial intelligence is helping doctors and nurses save time and see more patients. However, a Philips survey shows most healthcare work...

Lilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...

An accidental discovery in a rubber factory in the 1930s revealed that workers exposed to tetraethylthiuram disulfide experienced severe re...

A senior Home Department official stated that 965 Bangladeshi nationals were arrested in 2022, followed by 1,014 in 2023; 947 in 2024; and ...

The study, which followed patients for over five years, found that those ⁠who received ⁠the regimen were nine times more likely to have lit...

Novartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...

Harvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...

GSK's experimental hepatitis B drug, bepirovirsen, showed promising results in late-stage studies, with nearly one in five patients achievi...

Demand for vitamin and nutritional supplements is surging in India. This trend follows the increased availability of semaglutide-based weig...